Pfizer said Monday it would cut the price of its pneumococcal vaccine for the third time in three years as the pharmaceutical industry faces criticism over skyrocketing vaccine prices in developing markets.
via WSJ.com: US Business http://ift.tt/1BsG8HX
via WSJ.com: US Business http://ift.tt/1BsG8HX
Nessun commento:
Posta un commento